Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from C-Rad AB Class B ( ($SE:CRAD.B) ) is now available.
C-RAD has signed a strategic agreement with a leading healthcare provider in the Stuttgart region of Germany, valued at 9 MSEK. This contract includes the delivery of C-RAD’s advanced SGRT solutions, such as the Sentinel™ 4DCT and Catalyst+ HD™ systems, along with a long-term service agreement. The partnership marks a significant step in C-RAD’s expansion in Germany, enhancing their presence in the hospital caregiver segment and highlighting the growing importance of SGRT in modern radiation therapy.
More about C-Rad AB Class B
C-RAD is a company specializing in surface-guided radiation therapy (SGRT) solutions, which are designed to deliver precise and patient-centric cancer care. Their technology focuses on accurate dose delivery to tumors while protecting healthy tissue, using high-speed 3D cameras and augmented reality to enhance patient safety and treatment accuracy. C-RAD is listed on NASDAQ Stockholm.
Average Trading Volume: 40,645
Current Market Cap: SEK1.2B
See more data about CRAD.B stock on TipRanks’ Stock Analysis page.